These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32025925)

  • 1. Therapy for Insomnia and Circadian Rhythm Disorder in Alzheimer Disease.
    Ferini-Strambi L; Galbiati A; Casoni F; Salsone M
    Curr Treat Options Neurol; 2020 Feb; 22(2):4. PubMed ID: 32025925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapies for sleep disturbances in Alzheimer's disease.
    McCleery J; Cohen DA; Sharpley AL
    Cochrane Database Syst Rev; 2014 Mar; (3):CD009178. PubMed ID: 24659320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insomnia in Elderly Patients: Recommendations for Pharmacological Management.
    Abad VC; Guilleminault C
    Drugs Aging; 2018 Sep; 35(9):791-817. PubMed ID: 30058034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Sleep-Wake Disorders II: Focus on Insomnia and Circadian Rhythm Sleep Disorders.
    Spiegelhalder K; Nissen C; Riemann D
    Handb Exp Pharmacol; 2019; 253():261-276. PubMed ID: 28707143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of Safety and Efficacy of Sleep Medicines in Older Adults.
    Schroeck JL; Ford J; Conway EL; Kurtzhalts KE; Gee ME; Vollmer KA; Mergenhagen KA
    Clin Ther; 2016 Nov; 38(11):2340-2372. PubMed ID: 27751669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery.
    Atkin T; Comai S; Gobbi G
    Pharmacol Rev; 2018 Apr; 70(2):197-245. PubMed ID: 29487083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological advances in the treatment of insomnia.
    Richey SM; Krystal AD
    Curr Pharm Des; 2011; 17(15):1471-5. PubMed ID: 21476952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical management of sleep disturbances in Alzheimer's disease: current and emerging strategies.
    Urrestarazu E; Iriarte J
    Nat Sci Sleep; 2016; 8():21-33. PubMed ID: 26834500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Searching for new options for treating insomnia: are melatonin and ramelteon beneficial?
    Bellon A
    J Psychiatr Pract; 2006 Jul; 12(4):229-43. PubMed ID: 16883148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update of management of insomnia in patients with chronic orofacial pain.
    Almoznino G; Haviv Y; Sharav Y; Benoliel R
    Oral Dis; 2017 Nov; 23(8):1043-1051. PubMed ID: 28075519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of light therapy on sleep problems: A systematic review and meta-analysis.
    van Maanen A; Meijer AM; van der Heijden KB; Oort FJ
    Sleep Med Rev; 2016 Oct; 29():52-62. PubMed ID: 26606319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suvorexant, a Novel Dual Orexin Receptor Antagonist, for the Management of Insomnia.
    Han AH; Burroughs CR; Falgoust EP; Hasoon J; Hunt G; Kakazu J; Lee T; Kaye AM; Kaye AD; Ganti L
    Health Psychol Res; 2022; 10(5):67898. PubMed ID: 36726477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ramelteon for the treatment of insomnia.
    Borja NL; Daniel KL
    Clin Ther; 2006 Oct; 28(10):1540-55. PubMed ID: 17157111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bright light therapy for sleep disturbance in dementia is most effective for mild to moderate Alzheimer's type dementia: a case series.
    Sekiguchi H; Iritani S; Fujita K
    Psychogeriatrics; 2017 Sep; 17(5):275-281. PubMed ID: 28127845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of sleep dysfunction and psychiatric disorders.
    Becker PM; Sattar M
    Curr Treat Options Neurol; 2009 Sep; 11(5):349-57. PubMed ID: 19744401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.
    Sateia MJ; Buysse DJ; Krystal AD; Neubauer DN; Heald JL
    J Clin Sleep Med; 2017 Feb; 13(2):307-349. PubMed ID: 27998379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disturbance and strategies for reactivation of the circadian rhythm system in aging and Alzheimer's disease.
    Wu YH; Swaab DF
    Sleep Med; 2007 Sep; 8(6):623-36. PubMed ID: 17383938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of sleep dysfunction and psychiatric disorders.
    Becker PM
    Curr Treat Options Neurol; 2006 Sep; 8(5):367-75. PubMed ID: 16901376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suvorexant for insomnia: a systematic review of the efficacy and safety profile for this newly approved hypnotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L
    Int J Clin Pract; 2014 Dec; 68(12):1429-41. PubMed ID: 25231363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Update on Dual Orexin Receptor Antagonists and Their Potential Role in Insomnia Therapeutics.
    Janto K; Prichard JR; Pusalavidyasagar S
    J Clin Sleep Med; 2018 Aug; 14(8):1399-1408. PubMed ID: 30092886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.